Prof. Dr. Norbert Winkeljohann , 62 , is to become Chairman of the Supervisory Board of Bayer . As decided at the Supervisory Board meeting , Winkeljohann will succeed Werner Wenning , 73 , who is to step down with effect from the ending of the Annual Stockholders ’ Meeting on April 28 , 2020 . Winkeljohann serve as Chairman of the Board of Management of PricewaterhouseCoopers Europe SE until June 2018 and has been a member of Bayer ’s Supervisory Board since May 2018 . The shareowner representative butt on the Supervisory Board that would become vacant is set to be taken by former TUI Group CFO Horst Baier , 63 . The Supervisory Board decided to make a marriage offer to this consequence to the Annual Stockholders ' Meeting . If elect , Baier is set to replace Winkeljohann as Chairman of the Audit Committee .
Wenning has been Chairman of the Supervisory Board since 2012 and had been elected to dish up until 2022 . “ I had earlier been intending to ill-use down last year when I reached the standard years boundary set forth in the Supervisory Board ’s rules of procedure , ” Wenning said . However , in view of the society ’s situation at that clip , the Supervisory Board had ask him to stay on , he explain . “ Given my long - standing affiliation with this company , I was well-chosen to do so , ” Wenning said . Even before his late determination to step down , the Nominations Committee had been plow with the matter of succession planning for some time and had identify Winkeljohann as a candidate , he take note .
“ Bayer is lay down corking headway strategically and operationally – the consolidation of the acquired agriculture business sector is proceed very well and good onward motion is being made with the announced efficiency , morphologic and portfolio measures , ” Wenning said . “ Also , we have made and continue to make progress in handling the legal issues in the U.S. That ’s why now is a good meter to hand over to my replacement . I am proud of that in Mr. Winkeljohann , the Supervisory Board has prefer a loss leader who can pass Bayer into its next chapter as a prima and focussed life science ship’s company . ”
“ Mr. Wenning has helped forge Bayer for a smashing many years . We are very grateful to him – not least because he was willing to extend his terminal figure of berth again in 2019 to support the companionship , ” said Oliver Zühlke , Vice Chairman of the Supervisory Board . “ In Mr. Winkeljohann , we have name a fresh Chairman of the Supervisory Board who has acquired extraordinary expertness and extensive experience from his career in direction , auditing and consulting . Since join the Supervisory Board as Chairman of the Audit Committee , he has work diligently to familiarize himself with the Bayer Group ’s structure and businesses . This also applies to the collaborative social partnership that has serve Bayer so well , ” Zühlke added .
“ On behalf of the entire Board of Management , I ’d like to give thanks Mr. Wenning for his tremendous military service to the company . During the years he spent as Chairman of the Board of Management , he manage the company ’s strategical realignment . And under his leadership , the Supervisory Board has closely plump for the Board of Management and its effort to transform Bayer into a life science company , ” said Werner Baumann , Chairman of the Board of Management . “ We preen Mr. Winkeljohann on his appointment and calculate frontward to work with him in his new function . ”
